Search results

  1. T

    Trial Report A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long-COVID in Scotland: Part I, 2023, Mclaughlin

    Free: https://www.amjmed.com/article/S0002-9343(23)00460-6/fulltext A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long-COVID in Scotland: Part I Marie Mclaughlin, Ph.D Luke Cerexhe, MSc Eilidh Macdonald, BSc Rachel Meach, Ph.D David Carless, Ph.D Nicholas...
  2. T

    USA: News from the Bateman Horne Center

    "Haley Southwick recently completed a 330 hour training rotation at Bateman Horne Center for her doctorate of nursing program. She shares the highlights of her training experience in this": - 3-minute video - Guest blog https://batemanhornecenter.org/an-incredible-lifelong-impact/ "ME/CFS...
  3. T

    Thesis Thesis: Investigating the Genetic and Immunological Aetiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2022 Dibble

    See pre-print here: https://www.s4me.info/threads/comparison-of-t-cell-receptor-diversity-of-people-with-myalgic-encephalomyelitis-versus-controls-2023-dibble-ponting-et-al.34314/
  4. T

    Preprint Comparison of T-cell Receptor Diversity of people with Myalgic Encephalomyelitis versus controls, 2023, Dibble, Ponting et al

    Pre-print Free fulltext: https://www.researchsquare.com/article/rs-3164397/v1 Comparison of T-cell Receptor Diversity of people with Myalgic Encephalomyelitis versus controls Joshua J Dibble1 Ben Ferneyhough2 Matthew Roddis2 Sam Millington2 Michael D Fischer2 Nick J Parkinson2 Chris P...
  5. T

    Trial Report Invisibility and diagnosis stigma: disabling factors for female adults with ME/CFS in a small-scale qualitative study in England, 2023, Khalafbeigi

    Invisibility and diagnosis stigma: disabling factors for female adults with myalgia encephalomyelitis (ME)/chronic fatigue syndrome (CFS) in a small-scale qualitative study in England Free fulltext: https://www.emerald.com/insight/content/doi/10.1108/IJOT-08-2022-0032/full/html Abstract...
  6. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Well done to @MEActNetUK trustees, Denise Spreag, Janet Sylvester & Malcolm Bailey, your e-letter, “The ME community support NICE and reject the misguided attack in ‘Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic...
  7. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    As the second tweet says: “If accepted, our response will be published within 14 days, at which point we will share it publicly.”
  8. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Thanks to the World ME Alliance for coordinating a joint response which has been submitted now.
  9. T

    Daily Maverick - Collusion to exclude Long Covid - the long history of energy limiting disability denial by insurance firms

    It’s good if the issue is highlighted. But like a lot of articles, it doesn’t explain the mechanism as to how having CBT and/or GET seen as safe and effective allows disability insurance companies turn down claims (saying patients need to try CBT and/or GET before they will pay) which then leads...
  10. T

    Daily Maverick - Collusion to exclude Long Covid - the long history of energy limiting disability denial by insurance firms

    It links to this earlier piece I’ve just listened to: “Exhausting the exhausted – how employers & insurers cruelly add to the burden of Long Covid” (May 2023) by Sam Pearce Focuses on a man with Post Covid & Myalgic Encephalomyelitis. Insurers hope people will give up Audio version...
  11. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Some people might be interested in replying to Prof Michael Sharpe. See linked tweet. I'm blocked, so Prof Sharpe won't see my comments* but I can still reply to the thread by replying to Tim Glynn's tweet. *Though he might use a workaround like I have done given that he saw my initial tweet
  12. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Prestigious BMJ promotes ME/CFS misinformation 15th Jul 2023 Katie Johnstone The prestigious British Medical Journal (BMJ) has published an article which profoundly misrepresents the state of scientific knowledge on ME/CFS...
  13. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    I've seen someone say in a private conversation that e-letters to the Journal of Neurology, Neurosurgery & Psychiatry should be kept under 600 words because this is a BMJ Journal. That's not correct. See for example the second last e-letter published...
  14. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Well done to Dr Shepherd of the ME Association for his e-letter on the BMJ website https://www.bmj.com/content/382/bmj.p1621/rapid-responses
  15. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    I thought I would explain to this co-author the importance of the conflicts of interest.
  16. T

    Australia: News from Emerge Australia

    "ME/CFS And Long COVID Education In Demand At GPCE Sydney 2023" https://www.emerge.org.au/news/me-cfs-and-long-covid-education-in-demand-at-gpce-sydney-2023/
  17. T

    News from Australia

    Report on Parliamentary Friends For ME/CFS https://www.emerge.org.au/news/parliamentary-friends-for-me-cfs/
  18. T

    Anomalies in the review process and interpretation of the evidence in the NICE guideline for (CFS & ME), 2023, White et al

    Thanks. Hopefully there will be a number of responses. I’ve shared the guidelines you highlighted on Twitter along with a link to the web archive.
Back
Top